PlainRecalls
FDA Devices Moderate Class II Terminated

LeverEdge Contrast Injector: 35 cc syringe with ISO 594 female luer lock - Product Usage: intended to be used to perfuse contrast medias into the vessels for angiographic procedures, Catalog #: 4100-00.

Reported: May 12, 2021 Initiated: April 6, 2021 #Z-1529-2021

Product Description

LeverEdge Contrast Injector: 35 cc syringe with ISO 594 female luer lock - Product Usage: intended to be used to perfuse contrast medias into the vessels for angiographic procedures, Catalog #: 4100-00.

Reason for Recall

The firm received a complaint regarding particulate found in the packaging foam that could contaminate the sterile field.

Details

Recalling Firm
LeMaitre Vascular, Inc.
Units Affected
616 units
Distribution
Worldwide distribution - US Nationwide distribution in the states of AL, CA, FL, IL, IN, KY, MA, MO, NY, OH, TN, TX and the countries of Bahamas, Belgium, France, Germany, Hong Kong, Spain.
Location
Burlington, MA

Frequently Asked Questions

What product was recalled?
LeverEdge Contrast Injector: 35 cc syringe with ISO 594 female luer lock - Product Usage: intended to be used to perfuse contrast medias into the vessels for angiographic procedures, Catalog #: 4100-00.. Recalled by LeMaitre Vascular, Inc.. Units affected: 616 units.
Why was this product recalled?
The firm received a complaint regarding particulate found in the packaging foam that could contaminate the sterile field.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 12, 2021. Severity: Moderate. Recall number: Z-1529-2021.